Base de dados : HANSEN
Pesquisa : ANEMIA HEMOLITICA/IND QUIM [Descritor de assunto]
Referências encontradas : 3 [refinar]
Mostrando: 1 .. 3   no formato [Detalhado]

página 1 de 1

  1 / 3 HANSEN  
              next record last record
seleciona
para imprimir
Id:24736
Autor:Desforges, J. F; Thayer, W. W; Dawson, J. P
Título:Hemolytic anemia induced by sulfoxone therapy, with investigations into the mechanisms of its production
?-
Fonte:Boston; s.n; 1960. 5p p. ilus.
Resumo:A case report is presented of a patient in whom clinical evidence of hemolytic anemia with methemoglobinemia developed upon increasing the dosage of sulfoxone which he was receiving for Hansen's disease. Administration of the drug was withdrawn for six weeks, after which studies were made with the use of radioactive iron to demosntrate the hemolytic effect of sulfoxone. By means of tagging cells of a single age group, it was shown that the suceptibility to hemolysis was related to cell age, and it was only after the red cells had been in the circulation for approximately fifty days that they were subject to the hemolytic effects of this drug. No significant biochemical defect could be demonstrated in the erythrocytes of this patient. However, the decline in activity of glucose-6-phosphate dehydrogenase and glutathione reductase in the aging red cell and the reported sensitivity to this drug of patients with red cell deficiency of glucose-6-phosphate dehydrogenase suggest that the hemolytic mechanism is related to this enzyme system. The case demonstrates that drug-induced hemolytic anemia of this type may occur without demonstrable enzymatic defect of the erythrocytes. The observation that patients appear to compensate for the hemolytic anemia and methemoglobinemia if maintained on this drug may be explained by the fact that the older cells containing less adequate enzyme systems are removed from the circulation and an equilibrium is maintained by increased production of red cells with a shorter age span.
Descritores:HANSENOSTATICOS/admin
HANSENOSTATICOS/ef adv
HANSENOSTATICOS/sangue
HANSENOSTATICOS/uso terap
ANEMIA HEMOLITICA/ind quim
ANEMIA HEMOLITICA/diag
ANEMIA HEMOLITICA/etiol
HANSENIASE/clas
 HANSENIASE/compl
 HANSENIASE/diag
 HANSENIASE/terap
Limites:RELATO DE CASO
Localização:BR191.1; 00720/s


  2 / 3 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:17868
Autor:Kenner, D. J; Holt, K; Agnello, R; Chester, G. H
Título:Permanent retinal damage following massive dapsone overdose
..-
Fonte:s.l; s.n; oct. 1980. 4 p. ilus, graf.
Resumo:A massive dose of 7.5 g of 4,4'-diamino, diphenyl sulphone (dapsone) taken as a suicide attempt in a patient on long-term therapy for tuberculoid leprosy resulted in permanent bilateral retinal necrosis, previously unreported side effect of this drug. The patient developed a severe haemolytic anaemia, methaemoglobinaemia, and acute renal failure requiring peritoneal dialysis. It is proposed that the retinal damage was due to a combination of severe hypoxaemia and the physical effects of red cell fragmentation producing vascular occlusion in the macular and perimacular region, with consequent ischaemic necrosis...(AU).
Descritores:ANEMIA HEMOLITICA/ind quim
ANGIOFLUORESCEINOGRAFIA
INSUFICIÊNCIA RENAL AGUDA/ind quim
MACULA LUTEA
METEMOGLOBINEMIA/ind quim
DAPSONA/env
NECROSE
DOENCAS RETINIANAS/ind quim
TENTATIVA DE SUICIDIO
Limites:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Meio Eletrônico: - .
Localização:BR191.1; 00677/s


  3 / 3 HANSEN  
              first record previous record
seleciona
para imprimir
Id:13342
Autor:Kulkarni, A. G
Título:Treatment of leprosy
..-
Fonte:s.l; s.n; 1992. 1 p. .
Descritores:ANEMIA HEMOLITICA
CLOROQUINA
DEFICIENCIA DE GLUCOFOSFATO DESIDROGENASE
HANSENIASE
HANSENIASE
Localização:BR191.1; 06447/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information